The RhoA Activator GEF-H1/Lfc Is a Transforming Growth Factor-β Target Gene and Effector That Regulates α-Smooth Muscle Actin Expression and Cell Migration
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Maintenance of the epithelial phenotype is crucial for tissue homeostasis. In the retina, dedifferentiation and loss of integrity of the retinal pigment epithelium (RPE) leads to retinal dysfunction and fibrosis. Transforming growth factor (TGF)-β critically contributes to RPE dedifferentiation and induces various responses, including increased Rho signaling, up-regulation of α-smooth muscle actin (SMA), and cell migration and dedifferentiation. Cellular TGF-β responses are stimulated by different signal transduction pathways: some are Smad dependent and others Smad independent. Alterations in Rho signaling are crucial to both types of TGF-β signaling, but how TGF-β-stimulates Rho signaling is poorly understood. Here, we show that primary RPE cells up-regulated GEF-H1 in response to TGF-β. GEF-H1 was the only detectable Rho exchange factor increased by TGF-β1 in a genome-wide expression analysis. GEF-H1 induction was Smad4-dependant and led to Rho activation. GEF-H1 inhibition counteracted α-SMA up-regulation and cell migration. In patients with retinal detachments and fibrosis, migratory RPE cells exhibited increased GEF-H1 expression, indicating that induction occurs in diseased RPE in vivo. Our data indicate that GEF-H1 is a target and functional effector of TGF-β by orchestrating Rho signaling to regulate gene expression and cell migration, suggesting that it represents a new marker and possible therapeutic target for degenerative and fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903 · cited 2×
“…roles of different GEFs and GAPs as well as their regulation of expression and activity in particular signaling pathways is a major challenge, and recent evidence suggests that these proteins may be potential therapeutic targets for developing drugs to treat various diseases (Bos et al., 2007).”
BackgroundIkenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
Aijaz, S., D’Atri, F., Citi, S., Balda, M. S., & Matter, K. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.03.003 · Cited by 226 · cited 13×
“GEF-H1/Lfc is a guanine nucleotide exchange factor for RhoA (Benais-Pont et al., 2003; Aijaz et al., 2005; Birkenfeld et al., 2008).”
BackgroundMethodInfluentialSelf-citationBainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197 · cited 2×
“For the lentiviral constructs, either the CTD-VSV sequence or the VSV epitope cassette were cloned into the lentiviral pHR’IN plasmid (Bainbridge et al., 2001), giving rise to LNT-DN-GEF-H1 or LNTcontrol, respectively.”
MethodBirkenfeld, J., Nalbant, P., Yoon, S.-H., & Bokoch, G. M. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.02.006 · Cited by 190 · cited 1×
“GEF-H1/Lfc is a guanine nucleotide exchange factor for RhoA (Benais-Pont et al., 2003; Aijaz et al., 2005; Birkenfeld et al., 2008).”
BackgroundGEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction
Birukova, A. A., Adyshev, D., Gorshkov, B., Bokoch, G. M., Birukov, K. G., & Verin, A. D. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00259.2005 · Cited by 173 · cited 5×
“Three samples for each condition were obtained and the RNA quality analyzed using a Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). cDNA and subsequent cRNA were prepared as described previously (Chambers et al., 2003) and then hybridized to porcine GeneChip arrays according to Affymetrix (Santa Clara, CA) sta…”
BackgroundMethodInfluentialPAK4 mediates morphological changes through the regulation of GEF-H1
Callow, M. G., Zozulya, S., Gishizky, M. L., Jallal, B., & Smeal, T. (2005) · Journal of Cell Science · doi:10.1242/jcs.02313 · Cited by 169 · cited 2×
“Recent evidence also shows that GEF-H1 activation is regulated by phosphorylation and TNF-alpha (Zenke et al., 2004; Callow et al., 2005; Chang and Lee, 2006; Fujishiro et al., 2008; Kakiashvili et al., 2009; Nie et al., 2009), suggesting that GEF-H1 regulation occurs at different levels and is…”
BackgroundNalbant, P., Chang, Y.-C., Birkenfeld, J., Chang, Z.-F., & Bokoch, G. M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0041 · Cited by 148 · cited 2×
“These data thus indicate that the increased levels of GEF-H1 expression contribute to Rho activation in response to TGF- .”
BackgroundRyan, X. P., Alldritt, J., Svenningsson, P., Allen, P. B., Wu, G.-Y., Nairn, A. C., & Greengard, P. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.013 · Cited by 142
Transforming growth factor-β1 regulates macrophage migration via RhoA
Kim, J.-S., Kim, J.-G., Moon, M.-Y., Jeon, C.-Y., Won, H.-Y., Kim, H.-J., Jeon, Y.-J., Seo, J.-Y., Kim, J.-I., Kim, J., et al. (2006) · Blood · doi:10.1182/blood-2005-10-009191 · Cited by 134
Cited by
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Signaling pathway cooperation in TGF-β-induced epithelial–mesenchymal transition
Derynck, R., Muthusamy, B. P., & Saeteurn, K. Y. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.09.001 · Cited by 374
TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Caja, L., Dituri, F., Mancarella, S., Caballero-Diaz, D., Moustakas, A., Giannelli, G., & Fabregat, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051294 · Cited by 351
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Role of epithelial–mesenchymal transition in proliferative vitreoretinopathy
Tamiya, S., & Kaplan, H. J. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.02.008 · Cited by 160
Metadata
- Authors
- Tsapara, A., Luthert, P., Greenwood, J., Hill, C. S., Matter, K., & Balda, M. S.
- Venue
- Molecular Biology of the Cell
- Published
- 2010-03-15
- Volume
- 21
- Issue
- 6
- Pages
- 860-870
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2506244296
- Cited by
- 97
- References
- 11
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.